{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T15:59:10Z","timestamp":1781020750346,"version":"3.54.1"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:00:00Z","timestamp":1780963200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017412","name":"BD","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017412","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Surg."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Effective hemostasis in spinal surgery is critical, especially near sensitive structures such as the spinal cord and dorsal root ganglia. Flowable hemostatic agents offer targeted control in irregular, hard-to-reach areas. This study evaluates the safety and efficacy of flowable collagen hemostat (FC) in an ovine lumbar laminectomy model with open durotomy by making a direct comparison with the gelatin hemostatic matrix with thrombin (GM) and a no-treatment control (Sham).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Fifty-four Polypay sheep (27 F, 27 M) underwent lumbar laminectomy and open durotomy and then received FC, GM, or no treatment (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200918\/group). Hemostasis was assessed at 3\u2005min postapplication without tamponade. Neurological examinations were performed at periodic intervals, and tissues were collected on days 7, 45, and 120 for a histological analysis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Hemostasis was achieved in 100% of FC-treated sites, 94.4% of GM, and 72.2% of Sham. Sham-treated animals exhibited more severe and prolonged neurological deficits compared with those treated with FC or GM. Inflammation decreased significantly across all groups, from mild\/moderate on day 7 to minimal on day 45, and was barely detectable by day 120. FC was associated with favorable histological responses in both intradural and extradural spinal tissues, comparable to GM and Sham.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Flowable collagen hemostat was safe and effective when applied directly to the spinal cord and surrounding neurological tissues during laminectomy with open durotomy. Its performance was comparable to that of the gelatin hemostatic matrix with thrombin in terms of hemostatic efficacy and histological outcomes, with both agents demonstrating superior neurological recovery compared with the untreated Sham group.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fsurg.2026.1760993","type":"journal-article","created":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T15:17:18Z","timestamp":1781018238000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Safety and efficacy of flowable microfibrillar collagen hemostat in an ovine model of lumbar laminectomy and open durotomy compared with the gelatin-thrombin hemostatic matrix and control"],"prefix":"10.3389","volume":"13","author":[{"given":"Amie","family":"Rossi","sequence":"first","affiliation":[{"name":"Becton, Dickinson and Company","place":["Warwick, RI, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kasia","family":"Bradbury","sequence":"additional","affiliation":[{"name":"Becton, Dickinson and Company","place":["Warwick, RI, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kingsley","family":"Abode-Iyamah","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Mayo Clinic","place":["Jacksonville, FL, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Bohnen","sequence":"additional","affiliation":[{"name":"Neurosurgery One","place":["Littleton, CO, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darcy","family":"Gagne","sequence":"additional","affiliation":[{"name":"Becton, Dickinson and Company","place":["Warwick, RI, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.14245\/ns.2143196.598","article-title":"Hemostats in spine surgery: literature review and expert panel recommendations","volume":"19","author":"Le Huec","year":"2022","journal-title":"Neurospine"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1213\/ANE.0000000000001485","article-title":"Spine surgery and blood loss: systematic review of clinical evidence","volume":"123","author":"Willner","year":"2016","journal-title":"Anesth Analg"},{"key":"B3","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1177\/2192568219896295","article-title":"Comparing bleeding and thrombotic rates in spine surgery: an analysis of 119888 patients","volume":"11","author":"Pirkle","year":"2019","journal-title":"Global Spine J"},{"key":"B4","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1097\/ALN.0000000000000369","article-title":"Massive hemorrhage: a report from the anesthesia closed claims project","volume":"121","author":"Dutton","year":"2014","journal-title":"Anesthesiology"},{"key":"B5","doi-asserted-by":"publisher","first-page":"71S","DOI":"10.1177\/2192568219868475","article-title":"Minimizing blood loss in spine surgery","volume":"10","author":"Mikhail","year":"2020","journal-title":"Global Spine J"},{"key":"B6","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.spinee.2024.01.003","article-title":"Topical hemostatic agents in spinal surgery","volume":"24","author":"Shen","year":"2024","journal-title":"Spine J"},{"key":"B7","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/1472-6963-11-135","article-title":"Impact of bleeding-related complications and\/or blood product transfusions on hospital costs in inpatient surgical patients","volume":"11","author":"Stokes","year":"2011","journal-title":"BMC Health Serv Res"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1111\/j.1537-2995.2008.01703.x","article-title":"Hemostats, sealants, and adhesives: components of the surgical toolbox","volume":"48","author":"Spotnitz","year":"2008","journal-title":"Transfusion"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1007\/s10143-021-01684-1","article-title":"Topical hemostatic agents in neurosurgery, a comprehensive review: 15 years update","volume":"45","author":"Schonauer","year":"2022","journal-title":"Neurosurg Rev"},{"key":"B10","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/j.1538-7836.2007.02500.x","article-title":"The central role of thrombin in hemostasis","volume":"5","author":"Crawley","year":"2007","journal-title":"J Thromb Haemostasis"},{"key":"B11","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1111\/jth.13249","article-title":"Collagen-mediated hemostasis","volume":"14","author":"Manon-Jensen","year":"2016","journal-title":"J Thromb Haemostasis"},{"key":"B12","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1055\/s-0035-1558413","article-title":"Efficacy, security, and manageability of gelified hemostatic matrix in bleeding control during thoracic and lumbar spine surgery: FloSeal versus Surgiflo","volume":"77","author":"Landi","year":"2016","journal-title":"J Neurol Surg A Cent Eur Neurosurg"},{"key":"B13","year":""},{"key":"B14","doi-asserted-by":"publisher","first-page":"374","DOI":"10.4103\/0970-1591.70574","article-title":"Evolution of hemostatic agents in surgical practice","volume":"26","author":"Sundaram","year":"2010","journal-title":"Indian J Urol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"155","DOI":"10.2147\/MDER.S298207","article-title":"Avitene\u2122 microfibrillar collagen hemostat for adjunctive hemostasis in surgical procedures: a systematic literature review","volume":"14","author":"Cziperle","year":"2021","journal-title":"Med Devices (Auckl)"},{"key":"B16","year":""},{"key":"B17","year":"2020"},{"key":"B18","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1177\/01926233221135563","article-title":"Scientific and Regulatory Policy Committee best practices: recommended (\u201cbest\u201d) practices for informed (non-blinded) versus masked (blinded) microscopic evaluation in animal toxicity studies","volume":"50","author":"Bolon","year":"2022","journal-title":"Toxicol Pathol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.sdentj.2022.11.007","article-title":"Gelatin-based hemostatic agents for medical and dental application at a glance: a narrative literature review","volume":"34","author":"Irfan","year":"2022","journal-title":"Saudi Dent J"},{"key":"B20","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s12893-018-0398-z","article-title":"A systematic review on the use of topical hemostats in trauma and emergency surgery","volume":"18","author":"Chiara","year":"2018","journal-title":"BMC Surg"},{"key":"B21","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1007\/s00464-024-10806-x","article-title":"TAVAC: comprehensive review of currently available hemostatic products as adjunct to surgical hemostasis","volume":"38","author":"Sucandy","year":"2024","journal-title":"Surg Endosc"},{"key":"B22","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1080\/21548331.2018.1498279","article-title":"Floseal\u00ae only versus in combination in spine surgery: a comparative, retrospective hospital database evaluation of clinical and healthcare resource outcomes","volume":"46","author":"Ramirez","year":"2018","journal-title":"Hosp Pract (1995)"},{"key":"B23","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1177\/21925682211008835","article-title":"Effectiveness of a gelatin-thrombin matrix sealant (Floseal\u00ae) for reducing blood loss during microendoscopic decompression surgery for lumbar spinal canal stenosis: a retrospective cohort study","volume":"13","author":"Nomura","year":"2023","journal-title":"Global Spine J"},{"key":"B24","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s42825-025-00193-x","article-title":"Preparation and application of collagen-based hemostatic materials: a review","volume":"7","author":"Xu","year":"2025","journal-title":"Collagen Leather"},{"key":"B25","doi-asserted-by":"publisher","first-page":"123","DOI":"10.2147\/MDER.S411735","article-title":"Efficacy of flowable collagen hemostat evaluated in preclinical models of liver injury and spinal cord exposure","volume":"16","author":"Lake","year":"2023","journal-title":"Med Devices (Auckl)"},{"key":"B26","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.1016\/j.spinee.2014.01.050","article-title":"Evaluation of resorption and biocompatibility of collagen hemostats in the spinal epidural space","volume":"14","author":"Mizuno","year":"2014","journal-title":"Spine J"},{"key":"B27","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s10047-005-0296-x","article-title":"Clinical benefits and risk analysis of topical hemostats: a review","volume":"8","author":"Tomizawa","year":"2005","journal-title":"J Artif Organs"},{"key":"B28","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1227\/01.NEU.0000327031.98098.DD","article-title":"Comparative safety and efficacy of topical hemostatic agents in a rat neurosurgical model","volume":"63","author":"Ereth","year":"2008","journal-title":"Neurosurgery"},{"key":"B29","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1179\/016164101101198794","article-title":"Pre-clinical subdural tissue reaction and absorption study of absorbable hemostatic devices","volume":"23","author":"Barbolt","year":"2001","journal-title":"Neurol Res"},{"key":"B30","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.wneu.2016.02.052","article-title":"An experimental study of histopathologic effects of hemostatic agents used in spinal surgery","volume":"90","author":"Altun","year":"2016","journal-title":"World Neurosurg"}],"container-title":["Frontiers in Surgery"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fsurg.2026.1760993\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T15:17:19Z","timestamp":1781018239000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fsurg.2026.1760993\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,9]]},"references-count":30,"alternative-id":["10.3389\/fsurg.2026.1760993"],"URL":"https:\/\/doi.org\/10.3389\/fsurg.2026.1760993","relation":{},"ISSN":["2296-875X"],"issn-type":[{"value":"2296-875X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,9]]},"article-number":"1760993"}}